Generics Bulletin
HBW Insight
In Vivo
Medtech Insight
Pink Sheet
Scrip
Close
Search
Search
In Vivo
Generics Bulletin
HBW Insight
Medtech Insight
Pink Sheet
Scrip
Roche’s First Anti-TIGIT Data Support Dual Checkpoint Inhibition Strategy
May 15 2020
•
By
Mandy Jackson
Tiragolumab plus Tecentriq worked best in PD-L1 high NSCLC • Source: Shutterstock
More from ASCO
More from Conferences